Company News 12 Dec 2024 Orthocell Achieves Major Milestone with First Sales of Remplirâ„¢ in Singapore Orthocell has today announced the achievement of first sales of Remplirâ„¢ in Singapore, marking another significant milestone in its global commercialisation… Orthocell
Company News 02 Dec 2024 Orthocell successfully completes US FDA 510(k) regulatory study for Remplirâ„¢ Orthocell has today reached another significant milestone with the successful completion of its Remplirâ„¢ 510(k) nerve repair regulatory study, validating… Orthocell
